Eli Lilly attacks weight-loss drug knockoffs as competition intensifies
Eli Lilly unleashed a flurry of lawsuits against wellness centers, medical spas and others the pharmaceutical company accused of illegally…
Category: Eli Lilly
Eli Lilly Braces for More Out-of-Pocket Payments as Zepbound Obesity Pill Nears Phase III Readout
As Eli Lilly’s highly anticipated obesity medication, Zepbound (tirzepatide), approaches its Phase III clinical trial readout, the pharmaceutical giant is…
Busting Myths Around Weight Loss Medication
Summary: As the use of weight loss medications like Ozempic and Wegovy continues to rise, so do the misconceptions surrounding…
Ozempic and GLP-1s are Reshaping the Travel Industry
These groundbreaking weight loss medications have far-reaching implications, impacting not only individual health but also travel experiences and businesses. 🌎✈️…
GLP-1 Medications: Celebrities Share Their Experiences
In recent years, GLP-1 medications have become a beacon of hope for many struggling with weight management. These drugs, including…
Ongoing Research Explores Expanding Potential of GLP-1 Drugs
While GLP-1 medications like Ozempic, Wegovy and Mounjaro have skyrocketed in popularity for treating diabetes and obesity, researchers are working…
Obesity Market Poised to Soar to $150 Billion as Supply Meets Voracious Demand
The pharmaceutical industry’s obesity market is on the verge of an unprecedented boom, with analysts projecting it could swell to…
Debunking the Most Common Myths About Weight Loss Drugs
As medications like Ozempic, Wegovy and Mounjaro see soaring popularity for treating obesity, a number of myths and misconceptions about…
Understanding GLP-1 Medications
GLP-1 medications, such as semaglutide and liraglutide, are gaining popularity for their role in managing blood sugar levels and aiding…
